Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
35.52
-1.60 (-4.31%)
At close: Dec 31, 2025, 4:00 PM EST
36.00
+0.48 (1.35%)
After-hours: Dec 31, 2025, 7:46 PM EST
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.4 billion as of December 31, 2025. Its market cap has increased by 500.22% in one year.
Market Cap
5.40B
Enterprise Value
5.07B
1-Year Change
500.22%
Ranking
Category
Stock Price
$35.52
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.40B, an increase of 4,248.24%. That is a compound annual growth rate of 99.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.64B |
| Johnson & Johnson | 499.17B |
| AbbVie | 406.07B |
| UnitedHealth Group | 300.12B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.38B |
| Novo Nordisk | 227.63B |